EFFECT OF SIMVASTATIN ON EVOLUTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN C57BL/6 MICE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOSAYEBI GHASEM; GHEZAVATI A.; GHASAMI K.; PAYANI M.A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download Full-Text

Persian Verion

View:

804

Download:

Cites:

Information Journal Paper

Title

EFFECT OF SIMVASTATIN ON EVOLUTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN C57BL/6 MICE

Author(s)

MOSAYEBI GHASEM | GHEZAVATI A. | GHASAMI K. | PAYANI M.A. | Issue Writer Certificate

Keywords

SIMVASTATINQ2

EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITISQ3

MULTIPLE SCLEROSISQ2

NITRIC OXIDEQ2

URIC ACIDQ2

ANTIOXIDANT CAPACITYQ2

Abstract

Background and Purpose: SIMVASTATIN is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme, a reductase and widely used as cholesterol-lowering agent. It is a promising candidate for future treatment in MULTIPLE SCLEROSIS (MS), as it has been shown to exhibit immunomodulatory and anti-inflammatory effects. This study examined the effect of SIMVASTATIN on the evolution of EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE), as an animal model forms.Materials and Methods: EAE was induced by immunization of 8 week old C57BL/6 mice with MOG35-55 peptide with complete Freunds adjuvant. Therapy with SIMVASTATIN (1mg/kg/every day given as oral) was started on day 3 before the immunization until 25 day after immunization. Total ANTIOXIDANT CAPACITY (TAC) was assessed by ferric reducing-antioxidant power (FRAP) method. NITRIC OXIDE (NO) production was also estimated by Griess reaction.Results: The results show that SIMVASTATIN-treated mice had significantly less incidence and clinical score of EAE than non-treated (control) EAE induced mice (p=0.001 and p=0.0001, respectively).Moreover, treated mice displayed a significantly delayed disease onset compared with control mice. SIMVASTATIN significantly increased TAC and level serum URIC ACID (p=0.001), but had no effect on serum nitrite production.Conclusion: Our results suggest that SIMVASTATIN therapy may be effective in the prevention of symptomatic EAE. This resistance to encephalomyelitis may be associated with the inhibition of oxidative stress and the increase of ANTIOXIDANT CAPACITY

Cites

No record.

References

No record.

Cite

APA: Copy

MOSAYEBI, GHASEM, GHEZAVATI, A., GHASAMI, K., & PAYANI, M.A.. (2008). EFFECT OF SIMVASTATIN ON EVOLUTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN C57BL/6 MICE. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 17(61), 45-53. SID. https://sid.ir/paper/45907/en

Vancouver: Copy

MOSAYEBI GHASEM, GHEZAVATI A., GHASAMI K., PAYANI M.A.. EFFECT OF SIMVASTATIN ON EVOLUTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN C57BL/6 MICE. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2008;17(61):45-53. Available from: https://sid.ir/paper/45907/en

IEEE: Copy

GHASEM MOSAYEBI, A. GHEZAVATI, K. GHASAMI, and M.A. PAYANI, “EFFECT OF SIMVASTATIN ON EVOLUTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN C57BL/6 MICE,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 17, no. 61, pp. 45–53, 2008, [Online]. Available: https://sid.ir/paper/45907/en

Related Journal Papers